Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain

di Manso, Luis, De Velasco, Guillermo, Paz-Ares, Luis
Pubblicato in ESMO Open (2020)

Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature

di de Velasco, Guillermo, Munoz, Cesar, Sepulveda, Juan M., Castellano, Daniel
Pubblicato in Can Urol Assoc J (2015)

Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting

di de Velasco, Guillermo, Hamieh, Lana, Mickey, Suzanne, Choueiri, Toni K.
Pubblicato in Urol Oncol (2015)

Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma

di Carretero-González, Alberto, Salamanca Santamaría, Javier, Castellano, Daniel, de Velasco, Guillermo
Pubblicato in Medicine (Baltimore) (2019)

Exosomes: Definition, Role in Tumor Development and Clinical Implications

di Carretero-González, Alberto, Otero, Irene, Carril-Ajuria, Lucía, de Velasco, Guillermo, Manso, Luis
Pubblicato in Cancer Microenviron (2018)

In Reply

di de Velasco, Guillermo, Culhane, Aedín C., Heng, Daniel Y.C., Signoretti, Sabina, Choueiri, Toni K.
Pubblicato in Oncologist (2017)

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma

di Carril-Ajuria, Lucía, Santos, María, Roldán-Romero, Juan María, Rodriguez-Antona, Cristina, de Velasco, Guillermo
Pubblicato in Cancers (Basel) (2019)

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

di Carretero-González, Alberto, Otero, Irene, Lora, David, Carril-Ajuria, Lucía, Castellano, Daniel, de Velasco, Guillermo
Pubblicato in Oncoimmunology (2021)

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials

di Carretero-González, Alberto, Lora, David, Ghanem, Ismael, Otero, Irene, López, Flora, Castellano, Daniel, de Velasco, Guillermo
Pubblicato in Oncotarget (2019)

Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY215729...

di SEPULVEDA-SANCHEZ, JUAN, RAMOS, ANA, HILARIO, AMAYA, DE VELASCO, GUILLERMO, CASTELLANO, DANIEL, GARCIA DE LA TORRE, MARTA, RODON, JORDI, LAHN, MICHAEL F.
Pubblicato in Oncol Lett (2015)

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clini...

di Castellano, Daniel, Puente, Javier, de Velasco, Guillermo, Chirivella, Isabel, López-Criado, Pilar, Mohedano, Nicolás, Fernández, Ovidio, García-Carbonero, Icíar, González, María Belén, Grande, Enrique
Pubblicazione 2014

Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials

di Carretero-González, Alberto, Lora, David, Ghanem, Ismael, Zugazagoitia, Jon, Castellano, Daniel, Sepúlveda, Juan M., López-Martin, José A., Paz-Ares, Luis, de Velasco, Guillermo
Pubblicato in Oncotarget (2018)

The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

di Carretero-González, Alberto, Lora, David, Martín Sobrino, Isabel, Sáez Sanz, Irene, Bourlon, María T., Anido Herranz, Urbano, Martínez Chanzá, Nieves, Castellano, Daniel, de Velasco, Guillermo
Pubblicato in Cancers (Basel) (2020)

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study

di Hanna, Nawar, Sun, Maxine, Meyer, Christian P., Nguyen, Paul L., Pal, Sumanta K., Chang, Steven L., de Velasco, Guillermo, Trinh, Quoc-Dien, Choueiri, Toni K.
Pubblicato in J Clin Oncol (2016)

A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

di de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Pubblicato in Oncotarget (2020)

Comprehensive meta-analysis of key immune-related adverse events from CTLA-4 and PD-1/PD-L1 inhibitors in cancer patients

di de Velasco, Guillermo, Je, Youjin, Bossé, Dominick, Awad, Mark M., Ott, Patrick A., Moreira, Raphael B., Schutz, Fabio, Bellmunt, Joaquim, Sonpavde, Guru P., Hodi, F. Stephen, Choueiri, Toni K.
Pubblicato in Cancer Immunol Res (2017)

Tumor mutational load and immune parameters across metastatic Renal Cell Carcinoma (mRCC) risk groups

di de Velasco, Guillermo, Miao, Diana, Voss, Martin H., Hakimi, A. Ari, Hsieh, James J., Tannir, Nizar M., Tamboli, Pheroze, Appleman, Leonard J., Rathmell, W. Kimryn, Van Allen, Eliezer M., Choueiri, Toni K.
Pubblicato in Cancer Immunol Res (2016)

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma

di de Velasco, Guillermo, Gray, Kathryn P., Hamieh, Lana, Urun, Yuksel, Carol, Hallie A., Fay, Andre P., Signoretti, Sabina, Kwiatkowski, David J., McDermott, David F., Freedman, Matthew, Pomerantz, Mark M., Choueiri, Toni K.
Pubblicato in Eur Urol Focus (2016)

A phase I study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor targeted therapies

di McKay, Rana R., De Velasco, Guillermo, Werner, Lillian, Bellmunt, Joaquim, Harshman, Lauren, Sweeney, Christopher, Rosenberg, Jonathan E., Hirsch, Michelle, Signoretti, Sabina, Van Allen, Eliezer, Walsh, Meghara, Vaishampayan, Ulka, McDermott, David F., Choueiri, Toni K.
Pubblicato in Cancer (2016)

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma

di Trilla-Fuertes, Lucía, Miranda, Natalia, Castellano, Daniel, López-Vacas, Rocío, Farfán Tello, Carlos A., de Velasco, Guillermo, Villacampa, Felipe, López-Camacho, Elena, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Espinosa, Enrique, Fresno Vara, Juan Ángel, Pinto, Álvaro, Gámez-Pozo, Angelo
Pubblicato in PLoS One (2020)